Commit To Purchase Audentes Therapeutics At $30, Earn 12.2% Annualized Using Options
September 19, 2018 at 11:52 AM EDT
Investors eyeing a purchase of Audentes Therapeutics Inc (BOLD) stock, but tentative about paying the going market price of $39.60/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the February 2019 put at the $30 strike, which has a bid at the time of this writing of $1.50..